Levetiracetam G.L. Pharma (Levetiracetam)

Levetiracetam exerts its antiepileptic effect by binding to the synaptic vesicle protein SV2A. This binding modulates neurotransmitter release, stabilizing neuronal membranes and reducing the excessive neuronal firing that leads to seizure activity. The SV2A interaction is considered the primary mechanism behind its seizure‑controlling properties.

The dosage of levetiracetam is individualized and determined by the prescribing clinician based on the patient’s age, renal function, seizure type, and response to therapy. Healthcare professionals adjust the dose to achieve optimal seizure control while minimizing adverse effects.

Levetiracetam is classified as pregnancy category unknown, meaning that data are limited. Clinicians must weigh the potential benefits for seizure control against any possible risks to the fetus. Breastfeeding considerations are similar; the decision should be made jointly by the prescriber and the patient after reviewing the available information.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After receiving the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Levetiracetam offers a distinct mechanism of action through SV2A binding, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as valproate. It is generally well tolerated, has fewer drug‑enzyme interactions, and does not require routine therapeutic drug monitoring, making it a convenient option for many patients.

Levetiracetam tablets should be stored at ambient temperature, below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use.

Levetiracetam is taken orally, with or without food, as directed by the prescriber. Tablets should be swallowed whole with water and not crushed or chewed unless specifically advised. The dosing schedule (once, twice, or multiple times daily) is individualized based on therapeutic response.

Serious adverse reactions, although rare, include severe allergic responses (such as rash, swelling, or breathing difficulty), psychiatric events (including depression, suicidal thoughts, or aggression), and hematologic abnormalities like leukopenia or thrombocytopenia. Patients should seek immediate medical attention if any of these symptoms occur.

Levetiracetam is contraindicated in patients with known hypersensitivity to the drug or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled psychiatric disorders, or those taking interacting medications that may significantly reduce its efficacy. The prescriber should evaluate each patient’s medical history before initiating therapy.